Berlin, 4-5 May 2011: KOL & Stakeholder Engagement Europe

Healthcare Engagement Strategy e-journal is proud to have been selected as a media partner for the KOL & Stakeholder Engagement Europe, which takes place May 4-5, 2011 in Berlin, Germany.

We are delighted to provide a special discount of 300 €, when booking using code: CREATION

Here’s what Eyeforpharma’s Jon Gwillim says about the event:

With such a fast-changing industry landscape, it’s time to appropriately address the evolving role and impact of KOLs and non-medical KOLs on your future business strategy. There’s a need to:

  1. Identify & engage those individuals, groups or associations who are going to make a real difference to your drug development, market access and ultimate launch
  2. Align the objectives of your company with those of the KOL and work together to achieve these mutual goals
  3. Measure and monitor the long-term investment of successful KOL interactions

After 6 months of research, the main challenges I’m hearing are:

  • How to form a long-lasting collaborative relationship
    The latest approaches to strategically engage and interact with external experts and build a solid relationship
  • Effective identification and profiling techniques
    Match the right KOLs for your local, national and global strategy
  • How to navigate an increasingly strict regulatory landscape
    Work closely with your compliance team to establish a partnership model built on trust and transparency
  • Successful KOL management strategies in practice
    Improve internal communication, coordination and collaboration – facilitate knowledge-sharing across the organisation
  • How to engage with ‘new’ Opinion Leaders
    Recognise the importance & influence of non-clinical stakeholders on your business strategy

For more information about the KOL & Stakeholder Engagement Europe, click here.

Through truly impartial advice about strategy and implementation, Creation Healthcare helps organisations develop initiatives which are aligned with business goals, and which deliver return on investment.